Почетна › Рак на бели дробови со не-мали клетки › Илиноис › Cicero
Клинички испитувања за Рак на бели дробови со не-мали клетки во Cicero, IL
24 студии за Рак на бели дробови со не-мали клетки бараат учесници на локации во и околу Cicero (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Се регрутираФаза 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · на 10 милји
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Се регрутираФаза 3
- Edward Hines Jr VA Hospital, Hines · на 4 милји
- Advocate Christ Medical Center, Oak Lawn · на 9 милји
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Се регрутираФаза 3
- Northwestern Medicine Oak Brook, Oak Brook · на 9 милји
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Hope and Healing Cancer Services, Hinsdale · на 10 милји
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Се регрутираФаза 3
- Advocate Christ Medical Center, Oak Lawn · на 9 милји
- Hope and Healing Cancer Services, Hinsdale · на 10 милји
- Endeavor Health, Elmhurst · на 10 милји
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Се регрутираФаза 2
- Hope and Healing Clinical Research, Hinsdale · на 10 милји
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Се регрутираФаза 3
- Research Site, Hinsdale · на 10 милји
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Се регрутираФаза 3
- Affiliated Oncologists, LLC, Chicago Ridge · на 10 милји
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Се регрутираФаза 3
- Research Site, Hinsdale · на 10 милји
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Се регрутираФаза 2/3
- Loyola University Medical Center, Maywood · на 5 милји
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Се регрутираФаза 3
- Hope and Healing Cancer Services, Hinsdale · на 10 милји
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Affiliated Oncologists, LLC, Chicago Ridge · на 10 милји
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Се регрутираФаза 3
- Research Site, Hinsdale · на 10 милји
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Се регрутираФаза 3
- Research Site, Hinsdale · на 10 милји
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Се регрутираФаза 3
- Northwestern Medicine Oak Brook, Oak Brook · на 9 милји
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Се регрутираФаза 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · на 10 милји
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · на 3 милји
- Edward Hines Jr VA Hospital, Hines · на 4 милји
- Loyola University Medical Center, Maywood · на 5 милји
- и уште 2
MYLUNG Consortium Part 3: Observational Study
Се регрутираНабљудувачка студија
- Affiliated Oncologists, LLC, Chicago Ridge · на 10 милји
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Edward Hines Jr VA Hospital, Hines · на 4 милји
- Loyola University Medical Center, Maywood · на 5 милји
- Northwestern Medicine Oak Brook, Oak Brook · на 9 милји
- и уште 3
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2/3
- Loyola University Medical Center, Maywood · на 5 милји
- Northwestern Medicine Oak Brook, Oak Brook · на 9 милји
- Advocate Christ Medical Center, Oak Lawn · на 9 милји
- и уште 2
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Edward Hines Jr VA Hospital, Hines · на 4 милји
- Loyola University Medical Center, Maywood · на 5 милји
- Northwestern Medicine Oak Brook, Oak Brook · на 9 милји
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Се регрутираНабљудувачка студија
- Advocate Christ Medical Center, Oak Lawn · на 9 милји
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · на 9 милји
- Advocate High Tech Medical Park, Palos Heights · на 12 милји
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Се регрутира
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · на 4 милји
GEMINI-NSCLC: NSCLC Biomarker Study
Се регрутираНабљудувачка студија
- Hope and Healing Cancer Services, Hinsdale · на 10 милји
Испитувања за Рак на бели дробови со не-мали клетки во други градови
- Houston, TX145 студии
- New York City, NY121 студија
- Arlington, VA104 студии
- Nashville, TN97 студии
- Boston, MA90 студии
- Los Angeles, CA87 студии
- St. Louis, MO73 студии
- Chicago, IL61 студија
- Baltimore, MD60 студии
- San Antonio, TX59 студии
- Columbus, OH57 студии
- Washington, DC55 студии
Други студии во Cicero
- Рак на бели дробови17 студии
- Рак на простата14 студии
- Рак (сите типови)13 студии
- Рак на дојка11 студии
- Акутна миелоидна леукемија11 студии
- Колоректален карцином10 студии
- Рак на бешиката8 студии
- Меланом7 студии
- Кардиоваскуларни болести7 студии
- Метастатски карцином7 студии
- Множен миелом6 студии
- Беркитов лимфом6 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.